Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.01 (-2.17%)
At close: Nov 16, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Change in Accrued Expenses (2009 - 2026)

Updated

Protagenic Therapeutics, Inc.new (PTIX) posted Change in Accrued Expenses of $11,242 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$97,846 a year earlier.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Change in Accrued Expenses (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Change in Accrued Expenses at Protagenic Therapeutics, Inc.new was -$139,287; for FY2026 (ended Mar 31, 2026), it was $17,421, down 91.5% from FY2025.

  • Annual Change in Accrued Expenses shows a five-year compound annual growth rate of -44.8% (FY2021 to FY2026).
  • In prior fiscal years, Protagenic Therapeutics, Inc.new's Change in Accrued Expenses was $206,039 in FY2025, $463,127 in FY2024, -$183,832 in FY2023 and -$91,596 in FY2022.
  • Quarterly Change in Accrued Expenses has run from a low of -$155,028 in fiscal Q3 2026 to a high of $256,758 in fiscal Q1 2026 over five years.
  • According to Business Quant data, Change in Accrued Expenses for the three prior fiscal quarters was -$9,038 (Q1 2027), $13,537 (Q4 2026) and -$155,028 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.41 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 983.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 756.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn - 11,242.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11,242.00
Jun 30, 2026 -9,038.00
Mar 31, 2026 13,537.00
Dec 31, 2025 -155,028.00
Sep 30, 2025 -97,846.00
Jun 30, 2025 256,758.00
Mar 31, 2025 174,095.00
Dec 31, 2024 218,595.00
Sep 30, 2024 107,789.00
Jun 30, 2024 345,900.00
Mar 31, 2024 -209,157.00
Dec 31, 2023 -304,674.00
Sep 30, 2023 -109,567.00
Jun 30, 2023 123,197.00
Mar 31, 2023 107,212.00
Dec 31, 2022 145,557.00
Sep 30, 2022 93,511.00
Jun 30, 2022 -319,095.00
Mar 31, 2022 -11,569.00
Dec 31, 2021 102,052.00
API Access

Protagenic Therapeutics, Inc.new Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PTIX&period=max&api_key=YOUR_API_KEY